alirocumab
ravulizumab
gevokizumab
immunoglobulin D
ocrelizumab
hemagglutination
solitomab
sintilimab
zenocutuzumab
serofast
sasanlimab
toripalimab
seroprotein
dinutuximab
retifanlimab
heterophilic
guselkumab
immunospecific
vanucizumab
pozelimab
ziltivekimab
immunoglobulinemia
-umab
immunoprobe
immunochromatographic
carlumab
-a-
polytypic
evolocumab
-mab
monoantibody
agonistic monoclonal antibody
immunodensity
paraimmunoglobulinopathy
antiantibody
serum globulin
antiphospholipid antibody
-o-
affinity
antimonoclonal
patritumab
antigenic
serosuitable
lymphoplasmacytic
samalizumab
immunocomplexemia
hematoimmune
immunocytometric
immunoenrichment